DERIVES DE NAPHTHYRIDINE EN TANT QU'ANTAGONISTES D'ALPHA V BETA 6 INTEGRIN POUR LE TRAITEMENT DES TROUBLES FIBROTIQUES

L'invention concerne un composé de formule (i), ce dernier étant un acide 4-(3-fluoro-3-(2-(5, 6, 7, 8-tétrahydro-l, 8-naphthyridin-2-yl) éthyl) pyrrolidin-l-yl)-3-(3-(2-méthoxyéthoxy) phényl) butanoïque, ou un sel de ce dernier. A compound of formula (I): being 4-(3-Fluoro-3-(2-(5,6,7,8-tetrah...

Full description

Saved in:
Bibliographic Details
Main Authors PRITCHARD, John Martin, HANCOCK, Ashley Paul, ANDERSON, Niall Andrew, REDMOND, Joanna Mary, CAMPBELL-CRAWFORD, Matthew Howard James
Format Patent
LanguageFrench
Published 02.08.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:L'invention concerne un composé de formule (i), ce dernier étant un acide 4-(3-fluoro-3-(2-(5, 6, 7, 8-tétrahydro-l, 8-naphthyridin-2-yl) éthyl) pyrrolidin-l-yl)-3-(3-(2-méthoxyéthoxy) phényl) butanoïque, ou un sel de ce dernier. A compound of formula (I): being 4-(3-Fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.
Bibliography:Application Number: MA20150040580